Themis Medicare surges on incorporating wholly owned subsidiary
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Themis Medicare is currently trading at Rs. 1769.15, up by 61.60 points or 3.61% from its previous closing of Rs. 1707.55 on the BSE.
The scrip opened at Rs. 1745.00 and has touched a high and low of Rs. 1794.75 and Rs. 1745.00 respectively. So far 407 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1,794.75 on 21-Sep-2023 and a 52 week low of Rs. 875.10 on 11-Nov-2022.
Last one week high and low of the scrip stood at Rs. 1794.75 and Rs. 1670.10 respectively. The current market cap of the company is Rs. 1629.12 crore.
The promoters holding in the company stood at 67.16%, while Institutions and Non-Institutions held 0.05% and 32.79% respectively.
Themis Medicare has incorporated wholly owned subsidiary of the Company in the name of ‘Rx Themis’ on September 19, 2023 for manufacturing of Pharmaceuticals drugs including medicinal chemicals, fermentation products, natural products, synthetic products, feed supplements, cosmetics, etc.
Themis Medicare is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management, Critical Care and Anti-Infectives
